Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners

Bulletin Express

03/04

Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.

The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.

Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1118137844"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118137844\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118137844?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118137844","market":"us","top_or_hot":-1,"title":"Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners","media":"Bulletin Express","content":"<p>Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.</p>\n<p>The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.</p>\n<p>Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-04 19:21</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.</p>\n<p>The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.</p>\n<p>Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02135","symbol_name":"瑞麗醫美","start_time":0,"source_url":"","article_id":"1118137844","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118137844","pubTimestamp":1772623306,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02135":"瑞丽医美"},"translate_title":"瑞丽艾斯迈(02135)宣布2025财年亏损预期收窄，预计拥有人应占利润人民币200万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02135":1},"content_text":"Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.\nThe announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.\nShareholders and investors are advised to exercise caution when dealing in the shares of the Company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}